Clinical trial

Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer

NCT02810743

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2017-01-25

PhasePHASE3

Study timeline

Study start (actual)2017-01-25Date precision: day

Registry last updated2026-06-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

ddAC-CP-OlaparibDRUG

ddAC-mini CTCDRUG

Sponsors & collaborators

The Netherlands Cancer Institutelead sponsor

Mapped research locations

AmsterdamNetherlands2 ParisFrance1 MarseilleFrance1 GroningenNetherlands1 RotterdamNetherlands1 NijmegenNetherlands1 MaastrichtNetherlands1 UtrechtNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02810743 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.